KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 41 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $17,643,000 | -39.9% | 1,151,622 | 0.0% | 1.02% | -51.5% |
| Q2 2020 | $29,343,000 | +149.7% | 1,151,622 | +51.7% | 2.10% | +97.7% |
| Q1 2020 | $11,750,000 | +2.9% | 759,050 | -10.0% | 1.06% | -0.6% |
| Q2 2019 | $11,421,000 | -25.0% | 843,478 | 0.0% | 1.07% | -29.6% |
| Q1 2019 | $15,233,000 | +104.7% | 843,478 | +218.4% | 1.52% | +59.9% |
| Q4 2018 | $7,440,000 | +10.2% | 264,878 | 0.0% | 0.95% | +39.5% |
| Q3 2018 | $6,754,000 | +109.2% | 264,878 | +42.4% | 0.68% | +63.7% |
| Q2 2018 | $3,228,000 | – | 186,073 | – | 0.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Spearhead Capital Advisors, LLC | 202,580 | $2,601,000 | 2.82% |
| Lion Point Capital, LP | 480,000 | $5,140,000 | 1.13% |
| HHLR ADVISORS, LTD. | 2,920,023 | $37,493,000 | 0.99% |
| TANG CAPITAL MANAGEMENT LLC | 600,000 | $7,704,000 | 0.94% |
| Rubric Capital Management LP | 1,446,107 | $18,568,000 | 0.94% |
| AlphaCentric Advisors LLC | 43,000 | $552,000 | 0.57% |
| RICE HALL JAMES & ASSOCIATES, LLC | 749,933 | $9,629,000 | 0.56% |
| Parkman Healthcare Partners LLC | 126,192 | $1,620,000 | 0.46% |
| Birchview Capital, LP | 30,000 | $385,000 | 0.27% |
| Baker Brothers Advisors | 2,799,577 | $35,947,000 | 0.24% |